NewsNovo
The death of Huang Xiangbin, majority shareholder and former chairman of Sinco Pharmaceuticals, removes from the company the person who held its controlling ownership stake and previously led its executive operations.
Sinco confirmed the passing in a public announcement. The case for governance continuity turns on what succession framework, if any, governs the disposition of that controlling stake.
The weight of majority control A majority shareholder is not one voice among many. Majority status means the single holder controls the outcome of ordinary votes on corporate matters without needing coalition partners.
Huang occupied that position at Sinco.
Keep reading